Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection. 2018

Tasson C Rodrigues, and Maria Leonor S Oliveira, and Alessandra Soares-Schanoski, and Stefanni L Chavez-Rico, and Douglas B Figueiredo, and Viviane M Gonçalves, and Daniela M Ferreira, and Nitesh K Kunda, and Imran Y Saleem, and Eliane N Miyaji
Laboratório de Bacteriologia, Instituto Butantan, São Paulo, SP, Brazil.

Burden of pneumonia caused by Streptococcus pneumoniae remains high despite the availability of conjugate vaccines. Mucosal immunization targeting the lungs is an attractive alternative for the induction of local immune responses to improve protection against pneumonia. Our group had previously described the development of poly(glycerol adipate-co-ω-pentadecalactone) (PGA-co-PDL) polymeric nanoparticles (NPs) adsorbed with Pneumococcal surface protein A from clade 4 (PspA4Pro) within L-leucine microcarriers (nanocomposite microparticles-NCMPs) for mucosal delivery targeting the lungs (NP/NCMP PspA4Pro). NP/NCMP PspA4Pro was now used for immunization of mice. Inoculation of this formulation induced anti-PspA4Pro IgG antibodies in serum and lungs. Analysis of binding of serum IgG to intact bacteria showed efficient binding to bacteria expressing PspA from clades 3, 4 and 5 (family 2), but no binding to bacteria expressing PspA from clades 1 and 2 (family 1) was observed. Both mucosal immunization with NP/NCMP PspA4Pro and subcutaneous injection of the protein elicited partial protection against intranasal lethal pneumococcal challenge with a serotype 3 strain expressing PspA from clade 5 (PspA5). Although similar survival levels were observed for mucosal immunization with NP/NCMP PspA4Pro and subcutaneous immunization with purified protein, NP/NCMP PspA4Pro induced earlier control of the infection. Conversely, neither immunization with NP/NCMP PspA4Pro nor subcutaneous immunization with purified protein reduced bacterial burden in the lungs after challenge with a serotype 19F strain expressing PspA from clade 1 (PspA1). Mucosal immunization with NP/NCMP PspA4Pro targeting the lungs is thus able to induce local and systemic antibodies, conferring protection only against a strain expressing PspA from the homologous family 2.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D000327 Adsorption The adhesion of gases, liquids, or dissolved solids onto a surface. It includes adsorptive phenomena of bacteria and viruses onto surfaces as well. ABSORPTION into the substance may follow but not necessarily. Adsorptions
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D016130 Immunophenotyping Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. Lymphocyte Immunophenotyping,Lymphocyte Subtyping,Immunologic Subtyping,Immunologic Subtypings,Lymphocyte Phenotyping,Subtyping, Immunologic,Subtypings, Immunologic,Immunophenotyping, Lymphocyte,Immunophenotypings,Immunophenotypings, Lymphocyte,Lymphocyte Immunophenotypings,Lymphocyte Phenotypings,Lymphocyte Subtypings,Phenotyping, Lymphocyte,Phenotypings, Lymphocyte,Subtyping, Lymphocyte,Subtypings, Lymphocyte
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D053758 Nanoparticles Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging. Nanocrystalline Materials,Nanocrystals,Material, Nanocrystalline,Materials, Nanocrystalline,Nanocrystal,Nanocrystalline Material,Nanoparticle

Related Publications

Tasson C Rodrigues, and Maria Leonor S Oliveira, and Alessandra Soares-Schanoski, and Stefanni L Chavez-Rico, and Douglas B Figueiredo, and Viviane M Gonçalves, and Daniela M Ferreira, and Nitesh K Kunda, and Imran Y Saleem, and Eliane N Miyaji
December 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Tasson C Rodrigues, and Maria Leonor S Oliveira, and Alessandra Soares-Schanoski, and Stefanni L Chavez-Rico, and Douglas B Figueiredo, and Viviane M Gonçalves, and Daniela M Ferreira, and Nitesh K Kunda, and Imran Y Saleem, and Eliane N Miyaji
April 1997, Gene therapy,
Tasson C Rodrigues, and Maria Leonor S Oliveira, and Alessandra Soares-Schanoski, and Stefanni L Chavez-Rico, and Douglas B Figueiredo, and Viviane M Gonçalves, and Daniela M Ferreira, and Nitesh K Kunda, and Imran Y Saleem, and Eliane N Miyaji
June 2022, Pharmaceutics,
Tasson C Rodrigues, and Maria Leonor S Oliveira, and Alessandra Soares-Schanoski, and Stefanni L Chavez-Rico, and Douglas B Figueiredo, and Viviane M Gonçalves, and Daniela M Ferreira, and Nitesh K Kunda, and Imran Y Saleem, and Eliane N Miyaji
October 2018, Microbial pathogenesis,
Tasson C Rodrigues, and Maria Leonor S Oliveira, and Alessandra Soares-Schanoski, and Stefanni L Chavez-Rico, and Douglas B Figueiredo, and Viviane M Gonçalves, and Daniela M Ferreira, and Nitesh K Kunda, and Imran Y Saleem, and Eliane N Miyaji
June 2010, Microbial pathogenesis,
Tasson C Rodrigues, and Maria Leonor S Oliveira, and Alessandra Soares-Schanoski, and Stefanni L Chavez-Rico, and Douglas B Figueiredo, and Viviane M Gonçalves, and Daniela M Ferreira, and Nitesh K Kunda, and Imran Y Saleem, and Eliane N Miyaji
June 2007, Vaccine,
Tasson C Rodrigues, and Maria Leonor S Oliveira, and Alessandra Soares-Schanoski, and Stefanni L Chavez-Rico, and Douglas B Figueiredo, and Viviane M Gonçalves, and Daniela M Ferreira, and Nitesh K Kunda, and Imran Y Saleem, and Eliane N Miyaji
January 2011, Advances in oto-rhino-laryngology,
Tasson C Rodrigues, and Maria Leonor S Oliveira, and Alessandra Soares-Schanoski, and Stefanni L Chavez-Rico, and Douglas B Figueiredo, and Viviane M Gonçalves, and Daniela M Ferreira, and Nitesh K Kunda, and Imran Y Saleem, and Eliane N Miyaji
August 2019, Expert review of vaccines,
Tasson C Rodrigues, and Maria Leonor S Oliveira, and Alessandra Soares-Schanoski, and Stefanni L Chavez-Rico, and Douglas B Figueiredo, and Viviane M Gonçalves, and Daniela M Ferreira, and Nitesh K Kunda, and Imran Y Saleem, and Eliane N Miyaji
May 2010, PloS one,
Tasson C Rodrigues, and Maria Leonor S Oliveira, and Alessandra Soares-Schanoski, and Stefanni L Chavez-Rico, and Douglas B Figueiredo, and Viviane M Gonçalves, and Daniela M Ferreira, and Nitesh K Kunda, and Imran Y Saleem, and Eliane N Miyaji
October 2019, Immunologic research,
Copied contents to your clipboard!